Autolus Therapeutics PLC (AUTL)
4.40
+0.33
(+8.11%)
USD |
NASDAQ |
May 17, 16:00
4.40
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Cash from Investing (Quarterly): -1.477M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.477M |
| September 30, 2023 | -1.498M |
| June 30, 2023 | -4.389M |
| March 31, 2023 | -3.622M |
| December 31, 2022 | -0.633M |
| September 30, 2022 | -6.797M |
| June 30, 2022 | -2.64M |
| March 31, 2022 | -0.771M |
| December 31, 2021 | -1.585M |
| September 30, 2021 | -3.861M |
| Date | Value |
|---|---|
| June 30, 2021 | -1.511M |
| March 31, 2021 | -1.90M |
| December 31, 2020 | -5.472M |
| September 30, 2020 | -4.049M |
| June 30, 2020 | -2.523M |
| March 31, 2020 | -2.637M |
| December 31, 2019 | -1.914M |
| September 30, 2019 | -3.781M |
| June 30, 2019 | -5.644M |
| March 31, 2019 | -7.329M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-6.797M
Minimum
Sep 2022
-0.633M
Maximum
Dec 2022
-2.984M
Average
-2.637M
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | -0.358M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 0.0038M |
| TC BioPharm (Holdings) PLC | -- |
| Mereo BioPharma Group PLC | -0.70M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -24.83M |
| Cash from Financing (Quarterly) | 0.023M |
| Free Cash Flow | -156.57M |
| Free Cash Flow Per Share (Quarterly) | -0.1511 |
| Free Cash Flow Yield | -20.50% |